Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure

Patients with chronic heart failure (HF) are at increased risk of both fatal and nonfatal major adverse cardiovascular events. We used data from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) trials to assess the influence of nonfatal hospitalizations fo...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Circulation (New York, N.Y.) Jg. 116; H. 13; S. 1482
Hauptverfasser:	Solomon, Scott D, Dobson, Joanna, Pocock, Stuart, Skali, Hicham, McMurray, John J V, Granger, Christopher B, Yusuf, Salim, Swedberg, Karl, Young, James B, Michelson, Eric L, Pfeffer, Marc A
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 25.09.2007
Schlagworte:	Aftercare Aged Aged, 80 and over Angiotensin II Type 1 Receptor Blockers - therapeutic use Benzimidazoles - therapeutic use Death, Sudden, Cardiac - epidemiology Disease Progression Female Follow-Up Studies Heart Failure - drug therapy Heart Failure - mortality Hospitalization - statistics & numerical data Humans Male Middle Aged Proportional Hazards Models Randomized Controlled Trials as Topic - statistics & numerical data Survival Analysis Tetrazoles - therapeutic use
ISSN:	1524-4539, 1524-4539
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!